> In a setback for drug companies, European Court refuses to hear "parallel trading" case. Story [1]
> Oncologists criticize Italian firm for raising price of cancer drug from 60 cents per pill to $55. Story [2] (Wall Street Journal sub. req.)
> Boston Scientific warns that hundreds of patients with a faulty drug infusion port manufactured by the company may need surgery to replace the device. Story [3]
> The publisher of the bestselling What to Expect series launches an online spin-off of the pregnancy bible. Website [4]
> Fujitsu releases the LifeBook B6000, a stylish new notebook tweaked for the healthcare and pharma markets featuring a 12.6-inch touch screen and longer battery life. Story [5]
> "Bloodless surgery" continues to gain popularity. Story [6]
> Controversy over a lagging local EMR effort in Santa Clara, California. Story [7]
> Chutes & Ladders: Sutter Health CEO Van Johnson steps down effective today. Story [8]
And Finally... As hospitals diversify, some are offering alternative therapies. Story [9]
Links:
[1] http://www.nytimes.com/2005/06/01/business/worldbusiness/01glaxo.html
[2] http://online.wsj.com/article/0,,SB111759682982347969,00.html?mod=health_home_stories
[3] http://www.boston.com/business/globe/articles/2005/06/01/boston_scientific_recalls_device_after_fda_warning/
[4] http://www.whattoexpect.com
[5] http://www.computers.us.fujitsu.com/www/news.shtml?aboutus/pressreleases/pr_052405
[6] http://www.suntimes.com/output/health/cst-nws-blood01.html
[7] http://www.mercurynews.com/mld/mercurynews/news/11786150.htm
[8] http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2005/05/31/BUGILCVUFB1.DTL
[9] http://www.chicagotribune.com/news/local/chicago/chi-0505310109may31,1,2000502.story?coll=chi-newslocalchicago-hed&ctrack=2&cset=true